CN100413847C - 制备2-氨基甲基吡啶衍生物的方法 - Google Patents

制备2-氨基甲基吡啶衍生物的方法 Download PDF

Info

Publication number
CN100413847C
CN100413847C CNB2004800110082A CN200480011008A CN100413847C CN 100413847 C CN100413847 C CN 100413847C CN B2004800110082 A CNB2004800110082 A CN B2004800110082A CN 200480011008 A CN200480011008 A CN 200480011008A CN 100413847 C CN100413847 C CN 100413847C
Authority
CN
China
Prior art keywords
formula
acid
halogen atom
sodium
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB2004800110082A
Other languages
English (en)
Other versions
CN1777588A (zh
Inventor
J·斯托尔特林
B·伯顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9957269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN100413847(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer CropScience SA filed Critical Bayer CropScience SA
Publication of CN1777588A publication Critical patent/CN1777588A/zh
Application granted granted Critical
Publication of CN100413847C publication Critical patent/CN100413847C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

本发明涉及一种制备式(I)2-氨基甲基吡啶衍生物的新颖方法,该方法包括:第一步,在碱存在下,使式(II)的2-取代吡啶衍生物与式(III)的硝基烷烃反应,形成式(IV)的2-硝基甲基吡啶衍生物,第二步,在催化剂和酸存在下使形成的2-硝基甲基吡啶衍生物氢化,式中的n、X、Y、R1、R2和A按照说明书中定义。

Description

制备2-氨基甲基吡啶衍生物的方法
本发明涉及一种制备2-氨基甲基吡啶衍生物的新颖方法,所述衍生物是可用来制备杀虫剂的中间体,所述方法是卤代吡啶衍生物与硝基甲烷缩合,形成的2-硝基甲基吡啶衍生物随后催化氢化。
硝基乙烷与电子接受体取代的卤代苯的缩合反应已经被公开(Tetrahedron Lett.1990,31,1093-1096)。脂族硝基的还原是普遍已知的反应(cf.J.Org.Chem.1993,58,2302:用钯/碳和氢在二乙醚中的还原,cf.Tetrahedron Lett.1989,30,731:用Raney镍和氢的还原反应,cf.J.Org.Chem.1986,51,4856:用硼氢化钠和氯化镍六水合物催化剂的还原反应,cf.J.Org.Chem.1990,55,4474:用氢化铝锂的还原反应,cf.Org.Syn.Coll.1943,2,617:用锡在盐酸中还原反应,cf.J Am.Chem.Soc.1951,73,1293:用铁在盐酸中还原反应,cf.WO 02/055476:在成形的Raney催化剂存在下,与氢或含氢气体混合物的还原反应)。
当硝基甲基吡啶被另外的卤原子取代时,存在的困难是要避免吡啶环在还原步骤中的氢解脱卤(P.N.Rylander,氢化方法,Best Synthetic Series,Academic Press,1985,第148页)。因此,一般认为上述方法在没有显著的进一步改进下,不能应用于卤素取代的硝基甲基-吡啶衍生物。
现在,本发明人发现了一种没有上述缺陷的制备2-氨基甲基吡啶衍生物的方法,观察到这种方法只有痕量的脱卤产物,因此能应用于工业规模生产。
因此,本发明涉及一种制备下面通式(I)的2-氨基甲基吡啶衍生物或其盐的方法,
Figure C20048001100800051
其中,
n代表0、1、2或3,
X代表卤原子,
Y代表卤原子、卤代烷基、烷氧基羰基或烷基磺酰基,如果n为2或3,Y可以相同或不同,
R1代表氢、烷基、环烷基或环烷基甲基,
R2代表氢或烷基,
R1和R2还可以一起代表亚烷基,
该方法包括:第一步:在碱存在下使式(II)的2-取代吡啶衍生物与式(III)的硝基烷烃反应,
Figure C20048001100800061
其中
n、X和Y按照上面定义,和
A代表卤原子、三氟甲基磺酰基或甲基磺酰基,或其他能作为带负电荷的离去基团的基团,
Figure C20048001100800062
其中,
R1和R2按照上面定义,
形成式(IV)的2-硝基甲基吡啶衍生物
Figure C20048001100800063
其中,
n、X、Y、R1和R2按照上面定义,
第二步:式(IV)的2-硝基甲基吡啶衍生物在催化剂和一种酸存在下进行氢化。
式(II)提供了对作为进行本发明方法第一步的原料的2-取代吡啶衍生物的一般定义。
对式(II)的2-取代吡啶衍生物的基团的优选定义如下。
n较好代表0、1或2,更好代表0或1,最好是1。
X较好代表氟,氯或溴,更好代表氟或氯,最好是氯。
X较好位于吡啶环的3-位,即在A基团的邻位。
Y较好代表氟、氯、溴、有1-13个选自氟、氯和溴的卤原子的C1-C6-卤代烷基、(C1-C6-烷氧基)羰基环C1-C6-烷基磺酰基,更好代表氟、氯、溴、有1-9个选自氟、氯和溴的卤原子C1-C4-卤代烷基、(C1-C4-烷氧基)羰基或C1-C4-烷基磺酰基,最好是氯、三氟甲基、三氯甲基、甲氧基羰基、乙氧基羰基、正丙氧基羰基、异丙氧基羰基、甲基磺酰基或乙基磺酰基。
当n是1时,Y较好位于吡啶环5-位,即在A基团的对位。
A较好代表氟、氯、溴、三氟甲基磺酰基或甲基磺酰基,或其他能作为带负电荷离去基团的基团,更好代表氯、溴或三氟甲基磺酰基,最好是氯。
式(II)优选原料是2-取代吡啶衍生物,其中,n是1,X是氯,Y是C1-C4-卤代烷基,特别是三氟甲基,A是氯或三氟甲基磺酰基,特别是氯。
用作本发明方法原料的特别优选的式(II)2-取代吡啶衍生物是2,3-二氯-5-(三-氟甲基)吡啶。
式(II)的2-取代吡啶衍生物是已知的和/或可以采用已知方法制备。
式(III)提供对进行本发明方法第一步的原料的硝基烷烃的一般定义。
对式(III)硝基烷烃的基团的优选定义如下。
R1较好代表氢、C1-C6-烷基、C3-C8-环烷基或(C3-C8-环烷基)甲基,更好代表氢、C1-C6-烷基、C3-C6-环烷基或(C3-C6-环烷基)甲基,最好是氢、甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、正戊基、异戊基、新戊基、正己基、异己基、新己基、环丙基、环丁基、环戊基、环己基、环丙基甲基、环丁基甲基、环戊基甲基或环己基甲基。
R2较好代表氢或C1-C6-烷基,更好代表氢、甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、正戊基、异戊基、新戊基、正己基、异己基、新己基、最好代表氢、甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、正戊基、异戊基、正己基或异己基。
R1和R2还可以一起代表C2-C5-亚烷基,更好代表-(CH2)2-、-(CH2)3-、-(CH2)4-、-(CH2)5-。
式(III)的硝基烷烃是已知的化学物质。式(III)硝基烷烃的典型例子是:硝基甲烷、硝基乙烷、1-,2-硝基丙烷、2-硝基丙烷,1-,2-,3-,4-硝基丁烷,2-甲基-1-硝基丙烷,硝基环丙烷,硝基环丁烷,硝基环戊烷,硝基环己烷,硝基甲基环丙烷。这仅列举了式(III)硝基烷烃,并不构成对本发明范围的限制。
式(IV)提供了对作为进行本发明方法第二步原料的式(IV)2-硝基甲基吡啶衍生物的一般定义。
同样,对式(II)和(III)的较好,更好和最好的定义可应用于式(IV)的2-硝基甲基吡啶衍生物的基团。
式(IV)的2-硝基甲基吡啶衍生物是新颖化合物,也是本发明的一部分。
在所有情况下饱和或不饱和烃基如烷基和链烯基可以是直链或支链,只要可能,包括与杂原子的组合,如在烷氧基中。
本发明方法特别适合于制备2-氨基甲基-3-氯-5-三氟甲基吡啶,具体是,第一步:在叔丁醇钾、叔丁醇钠或氢氧化钾存在下,DMSO作为稀释剂,2,3-二氯-5-三氟甲基吡啶与硝基甲烷反应,形成3-氯-2-硝基甲基-5-三氟甲基吡啶,第二步:使用钯/碳作为催化剂,在盐酸中氢化,形成3-氯-2-氨基甲基-5-三氟甲基吡啶。
本发明的第一步在碱存在下进行。合适的碱是通常用于这类反应的任何无机碱和有机碱。较好的使用碱土金属或碱金属醇盐,如甲醇钠、乙醇钠、叔丁醇钾和异丁醇钠,碱金属和碱土金属氢氧化物,如氢氧化钠、氢氧化钙或氢氧化钾,碱金属碳酸盐或碳酸氢盐,如碳酸钠、碳酸钾、碳酸锂、碳酸铯、碳酸氢钾、碳酸氢钠,以及叔胺,如三甲胺,三乙胺,三丁胺,二异丙基乙胺,N,N-二甲基苯胺,吡啶,N-甲基哌啶,N,N-二甲基氨基吡啶,二氮杂二环辛烷(DABCO),二氮杂二环-壬烯(DBN)或二氮杂二环十一碳烯(DBU)。更好是甲醇钠、乙醇钠、叔丁醇钾、叔丁醇钠、异丁醇钠、氢氧化钠和氢氧化钾,最好是叔丁醇钾、叔丁醇钠、氢氧化钠和氢氧化钾。
本发明方法第一步可任选在稀释剂存在下进行。合适的稀释剂是常用的惰性有机溶剂。优选使用任选卤代脂族烃、脂环族烃或芳族烃,如石油醚,己烷,庚烷,环己烷,甲基环己烷,苯,甲苯,二甲苯或萘烷;氯苯,二氯苯,二氯甲烷;醚,如二乙醚,二异丙基醚,甲基叔丁基醚,甲基叔戊基醚,二噁烷,四氢呋喃,1,2-二甲氧基-乙烷,1,2-二乙氧基乙烷或苯甲醚;醇,如甲醇,乙醇,叔丁醇和异丁醇;腈,如乙腈,丙腈,正丁腈或异丁腈或苄腈;酰胺,如N,N-二甲基甲酰胺,N,N-二甲基乙酰胺,N-甲基甲酰苯胺,N-甲基吡咯烷酮或六甲基磷酸三酰胺(hexamethylphosphoric triamide);酯,如乙酸甲酯或乙酸乙酯;亚砜,如二甲基亚砜;或砜,如环丁砜。
本发明方法第一步中的反应温度可以在宽范围内变化。一般,在-20℃至+150℃,较好0℃至60℃,最好20℃至30℃进行该反应。
反应的第一步可以在大气压下进行,尽管也可以在减压或加压下进行。最好是大气压下进行该反应。
第一步的反应时间依据反应规模而不同,可以在1-48小时内变化,较好为3-24小时,最好是5-15小时。
实际进行所述方法的第一步时,例如,1mol式(II)的2-取代吡啶衍生物与1-10mol,较好1-5mol,更好1-3mol的式(III)烯基烷烃在1-10mol,较好1-5mol,更好1-3mol碱存在下反应。在某些情况还可以采用其他的比例。
本发明方法第二步在催化剂存在下进行。合适的催化剂有Raney镍,Raney钴,钯/碳,钯盐,铂和铂氧化物。优选Raney镍,Raney钴和钯/碳。具体的,钯/碳用量范围在式(IV)的2-硝基-甲基吡啶衍生物的0.0001-2当量。可以使用氯化铵作为助催化剂,其用量范围在0-10当量。为使脱卤化最小,加入催化剂抑制剂(如KBr)(cf.WO 02/16322)可能有利。
可以按照本领域技术人员已知的方法对催化剂再循环。特别是,通过过滤可以方便地再循环。
本发明方法的第二步可以在酸存在下进行。合适的酸可以是通常用于这类反应的任何无机酸和有机酸。优选使用无机酸,如盐酸、硫酸和磷酸;有机酸,如甲酸、乙酸、丙酸、三氟乙酸、三氯乙酸和甲磺酸。特别优选使用盐酸和乙酸。
本发明方法的第二步还可任选在稀释剂存在下进行。合适的稀释剂是常用的有机溶剂。优选使用任选卤代的脂族烃、脂环族烃或芳族烃,如石油醚,己烷,庚烷,环己烷,甲基环己烷,苯,甲苯,二甲苯或萘烷;氯苯,二氯苯,二氯甲烷;醚,如二乙醚,二异丙基醚,甲基叔丁基醚,甲基叔戊基醚,二噁烷,四氢呋喃,1,2-二甲氧基乙烷,1,2-二乙氧基乙烷或苯甲醚;醇,如甲醇,乙醇,叔丁醇和异丁醇;酰胺,如N,N-二甲基甲酰胺,N,N-二甲基乙酰胺,N-甲基甲酰苯胺,N-甲基吡咯烷酮或六甲基磷酸三酰胺;酯,如乙酸甲酯或乙酸乙酯;有机酸如乙酸。
本发明方法第二步的反应温度可以在宽范围内变化。反应一般在-20℃至+150℃,较好0℃至60℃,最好在20℃至30℃进行。
该第二步可在0.5至200bar,较好2至50bar,最好3至10bar氢压下进行。第二步的反应时间依据反应规模而不同,可以在1-48小时范围,较好为3-26小时。
实际进行该反应第二步时,例如,是1mol式(IV)的2-硝基甲基吡啶衍生物在催化剂存在下以及0-10mol,较好1-5mol,更好2-3mol的酸存在下进行。
下面,参照实施例说明本发明的方法。
制备例
实施例1(3-氯-2-硝基甲基-5-三氟甲基吡啶)
将叔丁醇钾(20.2g,0.18mol,2eq.)与90ml无水二甲基亚砜一起放入250ml三口烧瓶中。在干氩气气氛下,机械搅拌下缓慢加入硝基甲烷(11g,0.18mol,2eq.),同时用冰浴冷却。在20℃继续搅拌反应混合物15分钟。然后,在17℃,5分钟内加入2,3-二氯-5-三氟甲基吡啶(19.44g,0.09mol,1eq.)。温度先下降到13℃,而在添加结束后,观察到放热反应达到27℃。将混合物冷却至室温,再继续搅拌14小时。
将深棕色粗产物倒入150ml水中,随后用乙酸乙酯萃取三次,每次50ml。合并后的有机层每次用30ml水洗涤,共三次,随后在无水硫酸钠上干燥。过滤后,在20℃和150mbar减压下除去溶剂。
产量:22.8g 3-氯-2-硝基甲基-5-三氟甲基吡啶(95.7%理论产率,90.9%纯度)
1H NMR(d6-DMSO):δ=6.21(s,2H),8.68(d,1H),9.05(dd,1H)ppm。
MS(LC/MS-偶合):m/z(%)=243(36)和241(100)每个[M++H]。
实施例2(3-氯-2-硝基甲基-5-三氟甲基吡啶,PyMN)
将粉末氢氧化钾(9.35g,0.15mol,3eq.)与70ml无水DMSO一起放入250ml三口烧瓶中,在干氩气气氛下,机械搅拌下在30分钟内,加入溶解在30ml无水DMSO中的硝基甲烷(6.1g,0.1mol,2eq),同时用冰浴冷却,保持温度为20℃。在20℃再继续搅拌反应混合物15分钟。然后,一份加入2,3-二氯-5-三氟甲基吡啶(10.80g,0.05mol,1eq.),没有吸热或放热反应。混合物加热至50℃,在此温度搅拌3小时,然后冷却至室温。
将深棕色粗产物倒入500ml水中,加入稀盐酸进行酸化,随后用乙酸乙酯萃取三次,每次50ml。合并后的有机层每次用30ml水洗涤,共三次,随后在无水硫酸钠上干燥。过滤后,在20℃和150mbar减压下除去溶剂。
产量:9.72g 3-氯-2-硝基甲基-5-三氟甲基吡啶(73.9%理论产率,91.4%纯度)
实施例3(盐酸3-氯-2-氨基甲基-5-三氟甲基吡啶)
制备7.69g(0.211mol,2eq.)盐酸在无水甲醇的溶液,方法如下:用适量甲醇稀释30%甲醇(methanolic)HCl。将3-氯-2-硝基甲基-5-三氟甲基吡啶(25.9g,0.106mol,1eq.)和5.50g 5%钯/碳与上面制得的甲醇HCl一起放入哈斯特洛伊耐蚀镍基合金高压釜,在室温和5bar氢压下反应26小时。
调节压力至1bar后,过滤除去催化剂,用少量甲醇洗涤后,合并全部有机相,于30℃和150mbar减压下除去溶剂。
获得的粗产物悬浮于二氯甲烷进行纯化。过滤并用二氯甲烷洗涤后,浅灰色结晶在五氧化磷上干燥。
产量:24.13g盐酸3-氯-2-氨基甲基-5-三氟甲基吡啶(92.5%理论产率,99.9%纯度
1H NMR(d6-DMSO):δ=4.37(d,2H),8.61(d,1H),8.83(s宽,3H),9.03(d,1H)ppm。
MS(GC/MS-偶合):m/z(%)=212(13)和210(38)每个[M+],184(24)和182(79),30(100)。

Claims (9)

1. 一种制备通式(I)的2-氨基甲基吡啶衍生物或其盐的方法,
Figure C2004800110080002C1
其中,
n代表1,
X代表卤原子,且处于3-位
Y代表卤原子,或有1-13个选自氟、氯和溴的卤素原子的C1-C6卤代烷基,所述的Y处于5-位,
R1代表氢或C1-C6烷基,
R2代表氢或C1-C6烷基,或者
R1和R2还可以一起代表C2-C5亚烷基,
所述方法包括:第一步:在碱存在下,使式(II)的2-取代吡啶衍生物与式(III)的硝基烷烃反应,
其中,
n,X和Y按照上面定义,
A代表卤原子、三氟甲基磺酰基或甲基磺酰基,
其中,
R1和R2按照上面定义,
形成式(IV)的2-硝基甲基吡啶衍生物,
Figure C2004800110080003C1
其中,
n,X,Y,R1和R2按照上面定义,
第二步:在催化剂和酸存在下,使式(IV)的2-硝基甲基吡啶衍生物氢化。
2. 如权利要求1所述的方法,其特征在于,第一步中,使用甲醇钠、乙醇钠、叔丁醇钾、叔丁醇钠、异丁醇钠、氢氧化钠或氢氧化钾作为碱.
3. 如权利要求2所述的方法,其特征在于,第一步中,使用叔丁醇钾、叔丁醇钠、氢氧化钠或氢氧化钾作为碱。
4. 如权利要求1-3任一所述的方法,其特征在于,第二步中,使用Raney镍,Raney钴或钯/碳。
5. 如权利要求4所述的方法,其特征在于,在第二步中,钯/碳作为催化剂。
6. 如权利要求1-5中任一项所述的方法,其特征在于,在第二步中,使用盐酸、硫酸、磷酸、甲酸、乙酸、丙酸、三氟乙酸、三氯乙酸或甲磺酸。
7. 如权利要求6所述的方法,其特征在于,在第二步中,使用盐酸或乙酸作为酸。
8. 式(IV)的2-硝基甲基吡啶衍生物,
Figure C2004800110080003C2
其中
n代表1,
X代表卤原子,且处于3-位,
Y代表卤原子,或有1-13个选自氟、氯和溴的卤素原子的C1-C6卤代烷基,所述的Y在5-位上,
R1代表氢或C1-C6烷基,
R2代表氢或C1-C6烷基,或者
R1和R2还可以一起代表C2-C5亚烷基。
9. 一种制备如权利要求8所述的式(IV)2-硝基甲基吡啶衍生物的方法,该方法包括在碱存在下,使式(II)的2-取代吡啶衍生物与式(III)硝基烷烃反应,
Figure C2004800110080004C1
其中,
n,X和Y按照权利要求8所述定义
A代表卤原子、三氟甲基磺酰基、甲基磺酰基,
Figure C2004800110080004C2
其中,
R1和R2按照权利要求8所述定义。
CNB2004800110082A 2003-04-28 2004-04-26 制备2-氨基甲基吡啶衍生物的方法 Expired - Lifetime CN100413847C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0309631.0 2003-04-28
GBGB0309631.0A GB0309631D0 (en) 2003-04-28 2003-04-28 Novel process for the preparation of 2-aminomethylpyridine derivatives

Publications (2)

Publication Number Publication Date
CN1777588A CN1777588A (zh) 2006-05-24
CN100413847C true CN100413847C (zh) 2008-08-27

Family

ID=9957269

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004800110082A Expired - Lifetime CN100413847C (zh) 2003-04-28 2004-04-26 制备2-氨基甲基吡啶衍生物的方法

Country Status (15)

Country Link
US (1) US7608720B2 (zh)
EP (1) EP1620404B1 (zh)
JP (1) JP4718446B2 (zh)
KR (2) KR101213005B1 (zh)
CN (1) CN100413847C (zh)
AT (1) ATE356116T1 (zh)
BR (1) BRPI0409517A (zh)
DE (1) DE602004005175T2 (zh)
DK (1) DK1620404T3 (zh)
ES (1) ES2279383T3 (zh)
GB (1) GB0309631D0 (zh)
IL (1) IL170657A (zh)
PL (1) PL1620404T3 (zh)
TW (1) TWI359139B (zh)
WO (1) WO2004096772A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6083436B2 (ja) 2012-07-12 2017-02-22 日産化学工業株式会社 オキシム置換アミド化合物及び有害生物防除剤
CN106220555B (zh) * 2016-07-29 2019-06-21 天津市均凯化工科技有限公司 一种制备2-氨甲基-3-氯-5-三氟甲基吡啶的方法
TWI650318B (zh) * 2017-10-30 2019-02-11 財團法人工業技術研究院 以結晶法純化2,5-呋喃二甲酸的粗產物之方法與聚酯之形成方法
US11236070B2 (en) 2019-05-16 2022-02-01 Novartis Ag Chemical process
CN115819330A (zh) * 2022-12-28 2023-03-21 天津均凯农业科技有限公司 一种连续化制备2-氨基甲基-3-氯-5-三氟甲基吡啶的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5105011A (en) * 1989-07-20 1992-04-14 Rhone-Poulenc Chimie Process for the hydrogenation of halogenonitro-aromatic compounds in the presence of an iodide
WO2002016322A2 (en) * 2000-08-25 2002-02-28 Bayer Cropscience Sa Process for the preparation of 2-aminoethylpyridines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung
ZA885069B (en) * 1987-07-24 1989-03-29 Fujisawa Pharmaceutical Co Sustained-release percutaneous preparations
DE10101647A1 (de) 2001-01-16 2002-07-18 Degussa Verfahren zur Herstellung von substituierten Aminen durch Hydrierung von substituierten organischen Nitroverbindungen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5105011A (en) * 1989-07-20 1992-04-14 Rhone-Poulenc Chimie Process for the hydrogenation of halogenonitro-aromatic compounds in the presence of an iodide
WO2002016322A2 (en) * 2000-08-25 2002-02-28 Bayer Cropscience Sa Process for the preparation of 2-aminoethylpyridines

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Addition of nitroalkanes to ortho-halo-nitrobenzenes. Anewsynthesis of 4-chloro-7-(trifluoromethyl)quinoline. REID, J G,et al.Tetrahydron Letters,Vol.31 No.8. 1990
Addition of nitroalkanes to ortho-halo-nitrobenzenes. Anewsynthesis of 4-chloro-7-(trifluoromethyl)quinoline. REID, J G,et al.Tetrahydron Letters,Vol.31 No.8. 1990 *
Alkyl nitrate nitration of active methylene compounds.IX thenitration of alkyl substituted heterocyclic compounds. FEUER H,et al.Journal of organic chemistry,Vol.37 No.23. 1972
Alkyl nitrate nitration of active methylene compounds.IX thenitration of alkyl substituted heterocyclic compounds. FEUER H,et al.Journal of organic chemistry,Vol.37 No.23. 1972 *
Palladium-catalysed monoarylation of nitroalkanes. VOGL E M,et al.Journal of organic chemistry,Vol.67 . 2002
Palladium-catalysed monoarylation of nitroalkanes. VOGL E M,et al.Journal of organic chemistry,Vol.67 . 2002 *
Pyrido'2,3-d!dipyrimidines 8. Synthesis ofPyrrolo(2',3':4,5)pyrido'2,3-d!pyrimidines. BYSTRYAKOVA I D,et al.Chemistry of heterocyclic compounds. 1993
Pyrido'2,3-d!dipyrimidines 8. Synthesis ofPyrrolo(2',3':4,5)pyrido'2,3-d!pyrimidines. BYSTRYAKOVA I D,et al.Chemistry of heterocyclic compounds. 1993 *

Also Published As

Publication number Publication date
US7608720B2 (en) 2009-10-27
CN1777588A (zh) 2006-05-24
KR20060005396A (ko) 2006-01-17
TWI359139B (en) 2012-03-01
KR101213005B1 (ko) 2012-12-18
DE602004005175T2 (de) 2007-12-20
ATE356116T1 (de) 2007-03-15
DE602004005175D1 (de) 2007-04-19
EP1620404B1 (en) 2007-03-07
KR101130601B1 (ko) 2012-04-02
US20060235229A1 (en) 2006-10-19
GB0309631D0 (en) 2003-06-04
PL1620404T3 (pl) 2007-07-31
DK1620404T3 (da) 2007-04-02
IL170657A (en) 2011-02-28
WO2004096772A1 (en) 2004-11-11
JP4718446B2 (ja) 2011-07-06
EP1620404A1 (en) 2006-02-01
BRPI0409517A (pt) 2006-04-18
JP2006524665A (ja) 2006-11-02
ES2279383T3 (es) 2007-08-16
TW200502220A (en) 2005-01-16
KR20110133063A (ko) 2011-12-09

Similar Documents

Publication Publication Date Title
US20070161797A1 (en) Process for the manufacture of 2,3-dichloropyridine
JP4353633B2 (ja) (ヘテロ)芳香族ヒドロキシルアミンの製造方法
US8053572B2 (en) Alkyl-analide producing method
CN100413847C (zh) 制备2-氨基甲基吡啶衍生物的方法
KR101653025B1 (ko) 2-아미노-4-트리플루오로메틸피리딘류의 제조 방법
JP4412449B2 (ja) ジアミノレゾルシノール化合物の製造法
ES2644600T3 (es) Procedimiento de preparación de n-(5-cloro-2-isopropilbencil)ciclopropanamina
EP2079674B1 (en) Process for the preparation of trifluoroethoxytoluenes
JP4161290B2 (ja) ピリミジニルアルコール誘導体の製造方法及びその合成中間体
CN102356067B (zh) 通过亚胺氢化制备2,2-二氟乙胺衍生物的方法
KR100499679B1 (ko) 2-트리플루오로메톡시-아닐린의제조방법
KR20210154206A (ko) 치환된 2-[2-(페닐)에틸아미노]알칸아미드 유도체를 제조하는 방법
JP2006508156A (ja) 触媒として白金を用いたテルビナフィンの製造方法
CN116178198A (zh) 一种环丙氟虫胺的制备方法
JP2008069139A (ja) デラプリルの調製方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170825

Address after: cambridge

Patentee after: BAYER CROPSCIENCE GmbH

Address before: The German Rhine Monheim

Patentee before: BAYER CROPSCIENCE AG

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20080827